You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Venetoclax

Showing 351 - 366 of 366
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Acute Myeloid Leukemia Trial in Belgium (DC vaccine)

Recruiting
  • Acute Myeloid Leukemia
  • DC vaccine
  • Antwerp, Belgium
  • +7 more
Jan 15, 2021

Chronic Lymphoid Leukemia Trial in France (Ambulatory medical assistance)

Not yet recruiting
  • Chronic Lymphoid Leukemia
  • Ambulatory medical assistance
  • Saint Pierre, ILE DE LA Reunion, France
  • +15 more
Jul 29, 2022

Multiple Myeloma Trial in Darlinghurst, Fitzroy, Prahran (Venetoclax, ABBV-838, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Venetoclax
  • +2 more
  • Darlinghurst, Australia
  • +2 more
Jun 1, 2017

Quality of Life of Lymphomas Treated With Oral Therapy

Recruiting
  • Quality of Life
  • Questionnaire
  • Toulouse 9, France
    Loïc YSEBAERT
Apr 22, 2022

Acute Myeloid Leukemia Trial in Baltimore (Calaspargase pegol-mknl)

Recruiting
  • Acute Myeloid Leukemia
  • Calaspargase pegol-mknl
  • Baltimore, Maryland
    Greenebaum Cancer Center, University of Maryland Medical Systems
Dec 14, 2021

Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)

Terminated
Has Results
  • Leukemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 11, 2022

Mantle Cell Lymphoma Trial in France, United Kingdom (Ibrutinib + GA101 +GDC-0199)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Ibrutinib + GA101 +GDC-0199
  • Angers, France
  • +8 more
Mar 11, 2020

Chronic Lymphocytic Leukemia Electronic Patient Reported

Completed
  • CLL
  • Carevive CPS
  • Tampa, Florida
    Moffitt Cancer Institute
Aug 23, 2019

Cancer Trial in New York, Columbus (SNX-5422 plus ibrutinib)

Terminated
  • Cancer
  • SNX-5422 plus ibrutinib
  • New York, New York
  • +1 more
Feb 21, 2019

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (CC-122, Ibrutinib, Obinutuzumab)

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • La Jolla, California
  • +23 more
Aug 20, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Duvelisib, Venetoclax)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Tucson, Arizona
  • +9 more
Jul 22, 2016

Non-Hodgkin's Lymphoma Trial in Tucson, Lebanon, Hackensack (ABT-199, Ketoconazole)

Completed
  • Non-Hodgkin's Lymphoma
  • Tucson, Arizona
  • +2 more
Nov 16, 2017

Lupus Erythematosus Trial in Worldwide (ABT-199, Placebo)

Completed
  • Lupus Erythematosus
  • Clearwater, Florida
  • +14 more
Nov 16, 2017

Relapsed/Refractory Non-Hodgkin's Lymphoma Trial ([14C]ABT-199 (GDC-0199))

Withdrawn
  • Relapsed/Refractory Non-Hodgkin's Lymphoma
  • [14C]ABT-199 (GDC-0199)
  • (no location specified)
Aug 12, 2014

Non-Hodgkin's Lymphoma Trial in Hackensack (ABT-199, Rifampin)

Withdrawn
  • Non-Hodgkin's Lymphoma
  • Hackensack, New Jersey
    Site Reference ID/Investigator# 101416
May 22, 2014